ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus

Core Viewpoint - ImmuCell Corporation is shifting its strategic focus towards the First Defense product line and away from Re-Tain, with upcoming discussions on its unaudited sales results for 2025 [2][3]. Group 1: Strategic Changes - The company announced a strategic change in focus towards the First Defense product line on December 24, 2025 [2]. - The upcoming conference call on January 9, 2026, will address this strategic shift and the unaudited topline sales results for the fourth quarter and full year ended December 31, 2025 [3]. Group 2: Financial Results and Conference Calls - ImmuCell plans to release its full unaudited financial results for the quarter and year ended December 31, 2025, after the market closes on February 25, 2026 [4]. - A conference call to discuss these financial results is scheduled for February 26, 2026, at 9:00 AM ET [4]. Group 3: Company Overview - ImmuCell Corporation focuses on creating scientifically proven products that enhance cattle health and productivity, specifically through its First Defense product, which provides Immediate Immunity™ to newborn dairy and beef calves [5].